ARWR vs. QQQ
Compare and contrast key facts about Arrowhead Pharmaceuticals, Inc. (ARWR) and Invesco QQQ (QQQ).
QQQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Mar 10, 1999.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARWR or QQQ.
Correlation
The correlation between ARWR and QQQ is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARWR vs. QQQ - Performance Comparison
Key characteristics
ARWR:
-0.79
QQQ:
0.15
ARWR:
-1.15
QQQ:
0.38
ARWR:
0.87
QQQ:
1.05
ARWR:
-0.53
QQQ:
0.16
ARWR:
-1.74
QQQ:
0.58
ARWR:
30.11%
QQQ:
6.25%
ARWR:
66.38%
QQQ:
24.88%
ARWR:
-99.83%
QQQ:
-82.98%
ARWR:
-98.46%
QQQ:
-17.56%
Returns By Period
In the year-to-date period, ARWR achieves a -40.21% return, which is significantly lower than QQQ's -13.00% return. Over the past 10 years, ARWR has underperformed QQQ with an annualized return of 4.93%, while QQQ has yielded a comparatively higher 16.17% annualized return.
ARWR
-40.21%
-25.54%
-46.07%
-50.11%
-21.05%
4.93%
QQQ
-13.00%
-6.28%
-9.32%
4.93%
16.35%
16.17%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARWR vs. QQQ — Risk-Adjusted Performance Rank
ARWR
QQQ
ARWR vs. QQQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARWR vs. QQQ - Dividend Comparison
ARWR has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.67%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARWR Arrowhead Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ | 0.67% | 0.56% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% | 1.41% |
Drawdowns
ARWR vs. QQQ - Drawdown Comparison
The maximum ARWR drawdown since its inception was -99.83%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for ARWR and QQQ. For additional features, visit the drawdowns tool.
Volatility
ARWR vs. QQQ - Volatility Comparison
Arrowhead Pharmaceuticals, Inc. (ARWR) has a higher volatility of 30.46% compared to Invesco QQQ (QQQ) at 16.19%. This indicates that ARWR's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.